SCHEMBL7121746

SCHEMBL7121746

CC(C)(C)OC(=O)Nc1cccc(-c2csc(N)n2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 8/20 0.63
HDAC1 Q13547 6/20 0.63
HDAC2 Q92769 6/20 0.63
HDAC10 Q969S8 5/20 0.63
HDAC8 Q9BY41 4/20 0.63
HDAC6 Q9UBN7 4/20 0.62
NCOR2 Q9Y618 2/20 0.62
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
ALDH1A1 P00352 3/20 0.50
HTT P42858 2/20 0.50
LMNA P02545 2/20 0.50
CYP17A1 P05093 1/20 0.50
HPGD P15428 1/20 0.50
HRH4 Q9H3N8 1/20 0.49
MAPT P10636 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
MAPK1 P28482 1/20 0.48
TP53 P04637 1/20 0.48
FBP1 P09467 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7125440 0.85 SREBF2 (0.58) HDAC3HDAC1HDAC2HDAC10HDAC8
SCHEMBL3140270 0.82 SMN1; SMN2 (0.65) HDAC3HDAC1HDAC2HDAC10HDAC6
SCHEMBL23714788 0.79 HRH2 (0.50) HDAC3HDAC1HDAC2HDAC10HDAC8
SCHEMBL3786374 0.78 CYP17A1 (0.57) HDAC3HDAC1HDAC2HDAC10HDAC8
SCHEMBL16640661 0.78 SREBF2 (0.41) HDAC3HDAC1HDAC2HDAC10HDAC8
SCHEMBL7874987 0.77 ALDH1A1 (0.53) HDAC3HDAC1HDAC2HDAC10HDAC6
SCHEMBL3789848 0.77 CYP17A1 (0.62) HDAC3HDAC1HDAC2HDAC10HDAC8
SCHEMBL31671045 0.77 CYP17A1 (0.76) HDAC3HDAC1HDAC2HDAC10HDAC8
SCHEMBL26666910 0.77 CYP17A1 (0.76) HDAC3HDAC1HDAC2HDAC10HDAC8
SCHEMBL25362033 0.77 ALDH1A1 (0.51) HDAC3HDAC1HDAC2HDAC10HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD HDAC3 365/4885HDAC1 917/4885HDAC2 1584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.